- Release Date: 26/06/25 09:25
- Summary: US patent allowed for NNZ-2591 to treat Pitt Hopkins
- Price Sensitive: Yes
- Download Document 188.22KB
- Forums
- ASX - By Stock
- NEU
- Ann: US patent allowed for NNZ-2591 to treat Pitt Hopkins
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.51%
!
$16.93

Ann: US patent allowed for NNZ-2591 to treat Pitt Hopkins
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.93 |
Change
-0.260(1.51%) |
Mkt cap ! $2.136B |
Open | High | Low | Value | Volume |
$17.17 | $17.17 | $16.67 | $5.258M | 310.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2547 | $16.91 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.93 | 44 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30 | 17.080 |
1 | 108 | 17.000 |
1 | 2 | 16.930 |
1 | 59 | 16.710 |
1 | 100 | 16.700 |
Price($) | Vol. | No. |
---|---|---|
16.500 | 1501 | 3 |
16.700 | 1500 | 1 |
16.930 | 80 | 1 |
17.050 | 2500 | 1 |
17.180 | 350 | 1 |
Last trade - 16.10pm 20/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online